Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Search trials by disease or condition

Enter a condition, keyword, or NCT ID

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results matching your filters

MDT-0123 Japan StudyRecruiting
NCT07414745Phase 3Updated Sep 9, 2026
Sponsor: Medtronic Spinal and Biologics
Disc Degeneration · Spinal Deformity
Japan
Recurrent Ovarian CarcinoSarcoma Anti-pd-1 NiraparibRecruiting
NCT03651206Phase 2, Phase 3Updated Sep 9, 2026
Sponsor: ARCAGY/ GINECO GROUP
Ovarian Carcinosarcoma · Endometrial Carcinosarcoma
France, Italy, Spain
ATSN-201 Gene Therapy in RS1-Associated X-linked RetinoschisisRecruiting
NCT05878860Phase 3Updated Sep 9, 2026
Sponsor: Atsena Therapeutics Inc.
X-linked Retinoschisis
United States, Canada, United Kingdom
A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2)Recruiting
NCT07359846Phase 3Updated Sep 8, 2026
Sponsor: Generate Biomedicines
Severe Asthma
United States, Argentina, Australia, Belgium, Estonia +9 more
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical CancerRecruiting
NCT07061977Phase 3Updated Sep 8, 2026
Sponsor: National Cancer Institute (NCI)
Locally Advanced Cervical Adenocarcinoma · Locally Advanced Cervical Adenosquamous Carcinoma · Locally Advanced Cervical Squamous Cell Carcinoma · Stage IIIA Cervical Cancer FIGO 2018
United States, Puerto Rico
INTREPID: A Study of Sapablursen Evaluating the Safety and Efficacy in Participants With Polycythemia Vera (PV)Recruiting
NCT07429266Phase 3Updated Sep 8, 2026
Sponsor: Ono Pharmaceutical Co., Ltd.
Polycythemia Vera
United States, Australia, Japan
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk NeuroblastomaRecruiting
NCT06172296Phase 3Updated Sep 8, 2026
Sponsor: National Cancer Institute (NCI)
Ganglioneuroblastoma, Nodular · Neuroblastoma
United States, Australia, Canada, New Zealand, Puerto Rico
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung CancerRecruiting
NCT06119581Phase 3Updated Sep 8, 2026
Sponsor: Eli Lilly and Company
Carcinoma, Non-Small-Cell Lung · Neoplasm Metastasis
United States, Australia, Austria, Belgium, Brazil +24 more
Liposomal Bupivacaine Plus Plain Bupivacaine Versus Dexamethasone Plus Plain Bupivacaine in the Supraclavicular Brachial Plexus Block in Patients With Risk Factors for Severe Acute Postoperative PainRecruiting
NCT07665762Phase 3Updated Sep 8, 2026
Sponsor: The University of Hong Kong
Pain, Postoperative · Liposomal Bupivacaine · Dexamethasone · Supraclavicular Brachial Plexus Block
Hong Kong
REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - MinoritiesRecruiting
NCT06399705Phase 3Updated Sep 8, 2026
Sponsor: Weill Medical College of Cornell University
Coronary Artery Disease
United States
A Study of Orforglipron in Female Participants With Stress Urinary Incontinence Who Have Obesity or OverweightRecruiting
NCT07202884Phase 3Updated Sep 8, 2026
Sponsor: Eli Lilly and Company
Urinary Incontinence,Stress
United States, Canada, China, Czechia, India +5 more
A Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age With Moderate-to-Severe Atopic DermatitisRecruiting
NCT07711418Phase 3Updated Sep 8, 2026
Sponsor: Nektar Therapeutics
Moderate-to-Severe Atopic Dermatitis
United States
A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or OverweightRecruiting
NCT07369011Phase 3Updated Sep 8, 2026
Sponsor: Eli Lilly and Company
Sleep Apnea, Obstructive · Obesity · Overweight
United States, Australia, Brazil, Canada, China +6 more
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous TreatmentRecruiting
NCT06589804Phase 3Updated Sep 8, 2026
Sponsor: National Cancer Institute (NCI)
Metastatic Head and Neck Squamous Cell Carcinoma · Metastatic Hypopharyngeal Squamous Cell Carcinoma · Metastatic Laryngeal Squamous Cell Carcinoma · Metastatic Oral Cavity Squamous Cell Carcinoma
United States
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASHRecruiting
NCT06528314Phase 3Updated Sep 8, 2026
Sponsor: Akero Therapeutics, Inc
NASH - Nonalcoholic Steatohepatitis · MASH - Metabolic Dysfunction-Associated Steatohepatitis
United States, Argentina, Australia, Brazil, Canada +15 more
Comparison Between Local Radiotherapy Alone or Combined With Obinutuzumab in Early Stage Follicular Lymphoma: the GAZEBO Trial From the Fondazione Italiana LinfomiRecruiting
NCT05929222Phase 3Updated Sep 8, 2026
Sponsor: Fondazione Italiana Linfomi - ETS
Follicular Lymphoma
Italy
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])Recruiting
NCT04267848Phase 3Updated Sep 8, 2026
Sponsor: National Cancer Institute (NCI)
Lung Non-Small Cell Carcinoma · Lung Non-Small Cell Squamous Carcinoma · Lung Non-Squamous Non-Small Cell Carcinoma · Stage II Lung Cancer AJCC v8
United States, Guam
A Study to Learn About Revaccination With a Vaccine Called RSVpreF in Immunocompromised AdultsRecruiting
NCT07768345Phase 3Updated Sep 8, 2026
Sponsor: Pfizer
Respiratory Syncytial Virus (RSV)
United States
OPI-NXYDLD-303 Safety and Efficacy of Phentolamine Ophthalmic Solution in Keratorefractive Surgery Participants With Decreased Mesopic Visual AcuityRecruiting
NCT07140783Phase 3Updated Sep 8, 2026
Sponsor: Ocuphire Pharma, Inc.
Vision Loss Night · Vision Disorders
United States
A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast CancerRecruiting
NCT07647328Phase 3Updated Sep 8, 2026
Sponsor: AstraZeneca
ER-Positive HER2-Negative Breast Cancer
United States, France, Germany, Italy, Poland +4 more
Studying NMDA and Sigma-1 in Smoking Cessation Treatment (SUMMIT)Recruiting
NCT07766655Phase 3Updated Sep 8, 2026
Sponsor: Axsome Therapeutics, Inc.
Smoking Cessation
United States
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the KneeRecruiting
NCT07153471Phase 3Updated Sep 8, 2026
Sponsor: Eli Lilly and Company
Osteoarthritis
United States, Canada, China, Germany, Japan +2 more
Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-3)Recruiting
NCT07717892Phase 3Updated Sep 8, 2026
Sponsor: Axsome Therapeutics, Inc.
ADHD
United States
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)Recruiting
NCT07221149Phase 2, Phase 3Updated Sep 8, 2026
Sponsor: Bristol-Myers Squibb
Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma
United States, Argentina, Australia, Brazil, Canada +15 more
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung DiseaseRecruiting
NCT05878717Phase 2, Phase 3Updated Sep 8, 2026
Sponsor: GlaxoSmithKline
Systemic Sclerosis Associated Interstitial Lung Disease · Scleroderma, Systemic
United States, Argentina, Australia, Belgium, Brazil +13 more

Previous page Next page